Monoclonal antibody therapy of cancer
GP Adams, LM Weiner - Nature biotechnology, 2005 - nature.com
The most significant recent advances in the application of monoclonal antibodies (mAbs) to
oncology have been the introduction and approval of bevacizumab (Avastin), an anti …
oncology have been the introduction and approval of bevacizumab (Avastin), an anti …
Clinical radioimmunotherapy—the role of radiobiology
JP Pouget, I Navarro-Teulon, M Bardiès… - Nature reviews Clinical …, 2011 - nature.com
Conventional external-beam radiation therapy is dedicated to the treatment of localized
disease, whereas radioimmunotherapy represents an innovative tool for the treatment of …
disease, whereas radioimmunotherapy represents an innovative tool for the treatment of …
Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases
BACKGROUND. Medullary thyroid cancer (MTC) is a rare cancer. There is a relative paucity
of data over the last decade with regard to the prognosis of these patients. Therefore, the …
of data over the last decade with regard to the prognosis of these patients. Therefore, the …
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma
J Barbet, L Campion, F Kraeber-Bodéré… - The Journal of …, 2005 - academic.oup.com
Context: After unsuccessful surgery, medullary thyroid carcinoma (MTC) may be fatal or
remain stable for decades, and precise survival predictors are needed. Objective: This study …
remain stable for decades, and precise survival predictors are needed. Objective: This study …
Targeted therapy of cancer with radiolabeled antibodies
DM Goldenberg - Journal of Nuclear Medicine, 2002 - Soc Nuclear Med
This review focuses on the use of radiolabeled antibodies in the therapy of cancer, termed
radioimmunotherapy (RAIT). Basic problems concerning the choice of antibody and …
radioimmunotherapy (RAIT). Basic problems concerning the choice of antibody and …
[HTML][HTML] Treatment of advanced thyroid cancer with targeted therapies: ten years of experience
D Viola, L Valerio, E Molinaro, L Agate… - Endocrine-related …, 2016 - erc.bioscientifica.com
Thyroid cancer is rare, but it is the most frequent endocrine malignancy. Its prognosis is
generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such …
generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such …
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
S Hassfjell, MW Brechbiel - Chemical reviews, 2001 - ACS Publications
The three main weapons in the arsenal for cancer treatment continue to be surgery, external
beam radiotherapy, and chemotherapy. Nevertheless, inoperable tumors, tumors situated …
beam radiotherapy, and chemotherapy. Nevertheless, inoperable tumors, tumors situated …
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I …
F Kraeber-Bodéré, C Rousseau… - Journal of Nuclear …, 2006 - Soc Nuclear Med
Safety, targeting, and antitumor efficacy of pretargeted radioimmunotherapy using anti-
carcinoembryonic antigen (CEA) hMN-14× m734 bispecific antibody (BsmAb) and 131I-di …
carcinoembryonic antigen (CEA) hMN-14× m734 bispecific antibody (BsmAb) and 131I-di …
Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid Carcinomas
L Bodei, D Handkiewicz-Junak, C Grana… - Cancer biotherapy …, 2004 - liebertpub.com
Metastatic medullary thyroid cancer (MTC) shows a progressive course. Surgery is the only
curative treatment. In advanced disease, chemo-and radiotherapy show poor results. Newly …
curative treatment. In advanced disease, chemo-and radiotherapy show poor results. Newly …
Extent of disease and practice patterns for medullary thyroid cancer
E Kebebew, FS Greenspan, OH Clark… - Journal of the American …, 2005 - Elsevier
BACKGROUND: There have been significant improvements in the management of
medullary thyroid cancer (MTC), and consensus treatment guidelines have been …
medullary thyroid cancer (MTC), and consensus treatment guidelines have been …